Your session is about to expire
What is Photrexa
Flavin mononucleotideThe Generic name of this drug
Treatment SummaryRiboflavin is a coenzyme found in cells and tissues that is essential for the proper functioning of several oxidative enzymes, including NADH dehydrogenase.
Multi-Vit with Fluorideis the brand name
Photrexa Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Multi-Vit with Fluoride
Flavin mononucleotide
1997
19
When to interrupt dosage
The measure of Photrexa is contingent upon the diagnosed condition, such as prophylaxis of migraine headaches, Migraine and Vitamin B complex deficiency. The dosage amount fluctuates subject to the technique of delivery (e.g. Oral or Solution / drops) demonstrated in the table beneath.Condition
Dosage
Administration
Migraine
5.0 mg, , 15.0 mg, 0.6 mg/mL, 2.0 mg/mL, 1.4 mg/mL, 1.56 mg/mL, 1.46 mg/mL, 0.36 mg/mL, 3.6 mg/mL, 2.0 mg, 1.4 mg, 40.0 mg, 14.0 mg, 1.6 mg, 0.0016 mg/mg, 0.625 mg/mL, 10.0 mg/mL, 2.5 mg/mL, 0.2 mg/mL, 0.14 mg/mL, 0.07 mg/mL, 5.0 mg/mL, 0.7 mg/mL, 0.75 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.72 mg/mL, 6.0 mg/mL, 0.427 mg/mL, 0.18 mg/mL, 7.5 mg/mL, 0.1 mg/mL, 50.0 mg/mL, 0.4 mg/mL
, Oral, Elixir, Elixir - Oral, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Capsule, Capsule - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Injection - Intravenous, Intravenous, Solution / drops, Solution / drops - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Kit, Kit - Ophthalmic, Liquid, Liquid - Oral, Solution, Solution - Oral, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid; Tablet, Liquid; Tablet - Oral, Liquid - Intravenous, Syrup, Syrup - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule; Liquid, Capsule; Liquid - Oral, Powder, Powder - Oral
Vitamin B complex deficiency
5.0 mg, , 15.0 mg, 0.6 mg/mL, 2.0 mg/mL, 1.4 mg/mL, 1.56 mg/mL, 1.46 mg/mL, 0.36 mg/mL, 3.6 mg/mL, 2.0 mg, 1.4 mg, 40.0 mg, 14.0 mg, 1.6 mg, 0.0016 mg/mg, 0.625 mg/mL, 10.0 mg/mL, 2.5 mg/mL, 0.2 mg/mL, 0.14 mg/mL, 0.07 mg/mL, 5.0 mg/mL, 0.7 mg/mL, 0.75 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.72 mg/mL, 6.0 mg/mL, 0.427 mg/mL, 0.18 mg/mL, 7.5 mg/mL, 0.1 mg/mL, 50.0 mg/mL, 0.4 mg/mL
, Oral, Elixir, Elixir - Oral, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Capsule, Capsule - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Injection - Intravenous, Intravenous, Solution / drops, Solution / drops - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Kit, Kit - Ophthalmic, Liquid, Liquid - Oral, Solution, Solution - Oral, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid; Tablet, Liquid; Tablet - Oral, Liquid - Intravenous, Syrup, Syrup - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule; Liquid, Capsule; Liquid - Oral, Powder, Powder - Oral
Migraine Disorders
5.0 mg, , 15.0 mg, 0.6 mg/mL, 2.0 mg/mL, 1.4 mg/mL, 1.56 mg/mL, 1.46 mg/mL, 0.36 mg/mL, 3.6 mg/mL, 2.0 mg, 1.4 mg, 40.0 mg, 14.0 mg, 1.6 mg, 0.0016 mg/mg, 0.625 mg/mL, 10.0 mg/mL, 2.5 mg/mL, 0.2 mg/mL, 0.14 mg/mL, 0.07 mg/mL, 5.0 mg/mL, 0.7 mg/mL, 0.75 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.72 mg/mL, 6.0 mg/mL, 0.427 mg/mL, 0.18 mg/mL, 7.5 mg/mL, 0.1 mg/mL, 50.0 mg/mL, 0.4 mg/mL
, Oral, Elixir, Elixir - Oral, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Capsule, Capsule - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Injection - Intravenous, Intravenous, Solution / drops, Solution / drops - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Kit, Kit - Ophthalmic, Liquid, Liquid - Oral, Solution, Solution - Oral, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid; Tablet, Liquid; Tablet - Oral, Liquid - Intravenous, Syrup, Syrup - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule; Liquid, Capsule; Liquid - Oral, Powder, Powder - Oral
Avitaminosis
5.0 mg, , 15.0 mg, 0.6 mg/mL, 2.0 mg/mL, 1.4 mg/mL, 1.56 mg/mL, 1.46 mg/mL, 0.36 mg/mL, 3.6 mg/mL, 2.0 mg, 1.4 mg, 40.0 mg, 14.0 mg, 1.6 mg, 0.0016 mg/mg, 0.625 mg/mL, 10.0 mg/mL, 2.5 mg/mL, 0.2 mg/mL, 0.14 mg/mL, 0.07 mg/mL, 5.0 mg/mL, 0.7 mg/mL, 0.75 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.72 mg/mL, 6.0 mg/mL, 0.427 mg/mL, 0.18 mg/mL, 7.5 mg/mL, 0.1 mg/mL, 50.0 mg/mL, 0.4 mg/mL
, Oral, Elixir, Elixir - Oral, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Capsule, Capsule - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Injection - Intravenous, Intravenous, Solution / drops, Solution / drops - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Kit, Kit - Ophthalmic, Liquid, Liquid - Oral, Solution, Solution - Oral, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid; Tablet, Liquid; Tablet - Oral, Liquid - Intravenous, Syrup, Syrup - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule; Liquid, Capsule; Liquid - Oral, Powder, Powder - Oral
Iron Deficiency Anemia
5.0 mg, , 15.0 mg, 0.6 mg/mL, 2.0 mg/mL, 1.4 mg/mL, 1.56 mg/mL, 1.46 mg/mL, 0.36 mg/mL, 3.6 mg/mL, 2.0 mg, 1.4 mg, 40.0 mg, 14.0 mg, 1.6 mg, 0.0016 mg/mg, 0.625 mg/mL, 10.0 mg/mL, 2.5 mg/mL, 0.2 mg/mL, 0.14 mg/mL, 0.07 mg/mL, 5.0 mg/mL, 0.7 mg/mL, 0.75 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.72 mg/mL, 6.0 mg/mL, 0.427 mg/mL, 0.18 mg/mL, 7.5 mg/mL, 0.1 mg/mL, 50.0 mg/mL, 0.4 mg/mL
, Oral, Elixir, Elixir - Oral, Tablet, Tablet - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Capsule, Capsule - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Injection - Intravenous, Intravenous, Solution / drops, Solution / drops - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Ophthalmic, Kit, Kit - Ophthalmic, Liquid, Liquid - Oral, Solution, Solution - Oral, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Liquid; Tablet, Liquid; Tablet - Oral, Liquid - Intravenous, Syrup, Syrup - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule; Liquid, Capsule; Liquid - Oral, Powder, Powder - Oral
Photrexa Novel Uses: Which Conditions Have a Clinical Trial Featuring Photrexa?
66 active studies are now examining the potential of Photrexa in managing Iron deficiency anemia, Vitamin B complex deficiency and other Vitamin Deficiencies.Condition
Clinical Trials
Trial Phases
Avitaminosis
0 Actively Recruiting
Migraine
51 Actively Recruiting
Phase 4, Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1
Migraine Disorders
1 Actively Recruiting
Phase 3
Iron Deficiency Anemia
7 Actively Recruiting
Phase 3, Phase 4, Phase 2
Vitamin B complex deficiency
0 Actively Recruiting
Patient Q&A Section about photrexa
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is the cost of Photrexa?
"The manufacturer of a corneal cross-linking system (and the associated riboflavin formulas) has caused controversy by increasing the price of these products from $595 to $2,850."
Answered by AI
What is Photrexa?
"Photrexa is an eye drop that is designed to be used in conjunction with the KXL System. The KXL System is a machine that treats two eye conditions - progressive keratoconus and corneal ectasia as a result of surgery. These conditions can develop when the cornea, which is a part of the eye, becomes too thin. This can lead to vision problems."
Answered by AI
What is Photrexa viscous?
"The medication Photrexa Viscous and Photrexa are photo enhancers that are used in conjunction with the KXL System. This system is used to treat progressive keratoconus and corneal ectasia that has developed following refractive surgery."
Answered by AI
Clinical Trials for Photrexa
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.